Abstract
Favorable Prognosis in Patients Undergoing Hemodialysis Who Received a 23-Valent Pneumococcal Polysaccharide Vaccine Compared With Those Who Received a 13-Valent Pneumococcal Protein-Conjugate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have